$PPLPHARMA

### $PPLPHARMA | Strong FY26 Performance, Confident FY27 Outlook Piramal Finance reported a **210% YoY jump in FY26 consolidated net profit to ₹1,506 crore**, driven by strong retail lending growth and improving asset quality. **Net Interest Income (NII)** rose **32% YoY to ₹4,731 crore**, while **PPOP** increased **45% YoY to ₹2,294 crore**. Total **AUM grew 25% YoY to ₹1,01,230 crore**, led by a **33% rise in retail AUM**. The customer base expanded **22% YoY to 5.7 million**. The company also received multiple credit rating upgrades, including an upgrade to **AA+ / Stable**, reflecting improved financial strength. For **FY27**, management has guided for: * ~25% AUM growth * ~50% profit growth * RoAUM of ~2.5% **View:** Strong earnings growth, improving asset quality, and an optimistic FY27 outlook underline the company’s continued growth momentum.